By the end of 2026, 20 patients will receive the customized Russian mRNA vaccine against tumors, Alexander Gintsburg, scientific director of the Gamalia Center, said in an interview with Gazeta.ru. The first patient has already completed the course of treatment: after four months of observation, his metastases disappeared and no new tumors were discovered. Currently, five more people have started treatment.